Bogle Investment Management’s Boston Scientific BSX Stock Holding History

Bogle Investment Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-148,650	Closed	-$3.7M	–	308
2017 Q1	$3.7M	Buy	+148,650	New	+$3.61M	0.26%	118
2016 Q3	–	Sell	-287,742	Closed	-$6.72M	–	361
2016 Q2	$6.72M	Buy	+287,742	New	+$6.22M	0.47%	81
2015 Q2	–	Sell	-947,180	Closed	-$16.8M	–	363
2015 Q1	$16.8M	Hold	947,180	–	–	1.16%	10
2014 Q4	$12.6M	Buy	+947,180	New	+$12.1M	0.83%	27
2014 Q3	–	Sell	-874,284	Closed	-$11.2M	–	354
2014 Q2	$11.2M	Buy	874,284 +23,000	+3%	+$299K	0.75%	46
2014 Q1	$11.5M	Buy	851,284 +58,800	+7%	+$772K	0.79%	28
2013 Q4	$9.53M	Buy	792,484 +25,000	+3%	+$295K	0.8%	31
2013 Q3	$9.01M	Buy	767,484 +58,820	+8%	+$636K	0.91%	18
2013 Q2	$6.57M	Buy	+708,664	New	+$6.01M	0.8%	28

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bogle Investment Management's BSX Position: Q2 2017 in Review

Bogle Investment Management sold out of Boston Scientific (BSX) in Q2 2017, closing a stake of 148,650 shares — an estimated $3.7M sold.

Bogle Investment Management first reported a position in BSX in Q2 2013 and held it in 9 quarters. The position peaked at $16.8M in Q1 2015. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

Bogle Investment Management reported no remaining Boston Scientific position as of Q2 2017 after selling out during the quarter.
Bogle Investment Management sold 148,650 Boston Scientific shares in Q2 2017, an estimated $3.7M.
Bogle Investment Management first reported a position in Boston Scientific in Q2 2013 and held it in 9 quarters.
Bogle Investment Management's Boston Scientific position peaked at $16.8M in Q1 2015.
558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Bogle Investment Management's 13F filing for Q2 2017, filed 14 Aug 2017.